SCHEMBL8543014

SCHEMBL8543014

Cn1c(=O)c(N)c(-c2ccccc2Cl)c2cc(Cl)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.44
USP2 O75604 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
CHEK1 O14757 1/20 0.43
WEE1 P30291 1/20 0.43
NTRK1 P04629 1/20 0.42
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
DPP4 P27487 4/20 0.41
HCRTR1 O43613 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
FGFR1 P11362 1/20 0.40
SRC P12931 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539176 0.88 KDM4E (0.43) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL8541594 0.85 KDM4E (0.44) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL8538348 0.85 PGR (0.42) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL9359195 0.84 CYP1A1 (0.43) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL8544707 0.81 KMT2A (0.47) KDM4EKMT2AMAPTMEN1CHEK1
SCHEMBL30574986 0.80 WEE1 (0.44) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL8543548 0.79 CHEK1 (0.40) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL11409763 0.77 DPP4 (0.50) KDM4EMAPTCHEK1WEE1DPP4
Hydrochloric Acid SCHEMBL11419012 0.76 DPP4 (0.49) KDM4EMAPTCHEK1WEE1DPP4
SCHEMBL8784656 0.76 ALDH1A1 (0.54) KDM4EKMT2AMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623112-B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER (US) 1998-12-30 EP disclosed
US-5565472-A 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER INC. (US) 1996-10-15 US disclosed
EP-0623112-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1994-11-09 EP disclosed
WO-1993015058-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1993-08-05 WO disclosed